Research Article

Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes

Table 3

Correlation between serum fibroblast growth factor 21 levels and clinical variables among the 126 patients with type 2 diabetes mellitus.

VariablesLogarithmically transformed fibroblast growth factor 21 (pg/mL)
UnivariateMultivariate
R valueBetaAdjusted R2change value

Women0.1720.055
Hypertension0.2010.024
Age (years)0.1210.179
Height (cm)–0.0590.513
Body weight (kg)0.1680.060
Body mass index (kg/m2)0.2590.003
Waist circumference (cm)0.3010.001
Body fat mass (%)0.359<0.0010.2180.2180.008
SBP (mmHg)0.1910.032
DBP (mmHg)0.1800.043
Total cholesterol (mg/dL)0.1630.068
Log-triglyceride (mg/dL)0.499<0.0010.3570.036<0.001
HDL-C (mg/dL)–0.2190.014
LDL-C (mg/dL)0.1760.049
Log-glucose (mg/dL)0.1870.036
Log-HbA1c (%)0.0590.517
Log-BUN (mg/dL)0.0010.996
Log-creatinine (mg/dL)0.1940.029
eGFR (mL/min)–0.325<0.001–0.2050.0330.013
Log-UACR (mg/g)0.1980.031
Log-insulin (μIU/mL)0.334<0.001
Log-HOMA-IR0.358<0.001

Data of triglyceride, glucose, HbA1c, BUN, creatinine, UACR, insulin, and HOMA-IR levels showed skewed distribution and therefore were log-transformed before analysis. Analysis of data was done using the univariate linear regression analysis or multivariate stepwise linear regression analysis (adapted factors were hypertension, body mass index, waist circumference, body fat mass, SBP, DBP, log-triglyceride, HDL-C, LDL-C, log-glucose, log-creatinine, eGFR, log-UACR, insulin, and HOMA-IR). SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycated hemoglobin; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; UACR, urine albumin-to-creatinine ratio; HOMA-IR, homeostasis model assessment of insulin resistance. was considered statistically significant.